CN113801010A - Preparation method of 5-bromo-2-chlorobenzoic acid - Google Patents
Preparation method of 5-bromo-2-chlorobenzoic acid Download PDFInfo
- Publication number
- CN113801010A CN113801010A CN202111365309.7A CN202111365309A CN113801010A CN 113801010 A CN113801010 A CN 113801010A CN 202111365309 A CN202111365309 A CN 202111365309A CN 113801010 A CN113801010 A CN 113801010A
- Authority
- CN
- China
- Prior art keywords
- reaction
- acid
- bromo
- sodium
- carrying
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- FGERXQWKKIVFQG-UHFFFAOYSA-N 5-bromo-2-chlorobenzoic acid Chemical compound OC(=O)C1=CC(Br)=CC=C1Cl FGERXQWKKIVFQG-UHFFFAOYSA-N 0.000 title claims abstract description 19
- 238000002360 preparation method Methods 0.000 title claims abstract description 19
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 36
- 238000006243 chemical reaction Methods 0.000 claims abstract description 24
- 239000003153 chemical reaction reagent Substances 0.000 claims abstract description 16
- 238000005658 halogenation reaction Methods 0.000 claims abstract description 16
- CUKXRHLWPSBCTI-UHFFFAOYSA-N 2-amino-5-bromobenzoic acid Chemical compound NC1=CC=C(Br)C=C1C(O)=O CUKXRHLWPSBCTI-UHFFFAOYSA-N 0.000 claims abstract description 14
- 239000003638 chemical reducing agent Substances 0.000 claims abstract description 13
- 239000002904 solvent Substances 0.000 claims abstract description 13
- 238000006193 diazotization reaction Methods 0.000 claims abstract description 12
- 238000006722 reduction reaction Methods 0.000 claims abstract description 12
- 230000002140 halogenating effect Effects 0.000 claims abstract description 9
- SLAMLWHELXOEJZ-UHFFFAOYSA-N 2-nitrobenzoic acid Chemical compound OC(=O)C1=CC=CC=C1[N+]([O-])=O SLAMLWHELXOEJZ-UHFFFAOYSA-N 0.000 claims abstract description 8
- 238000004519 manufacturing process Methods 0.000 claims abstract description 7
- 238000005886 esterification reaction Methods 0.000 claims abstract description 5
- 239000003513 alkali Substances 0.000 claims abstract description 4
- 238000006460 hydrolysis reaction Methods 0.000 claims abstract description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 42
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 39
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 36
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 26
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 24
- 238000000034 method Methods 0.000 claims description 21
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 15
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 15
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 14
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 14
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 claims description 12
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 claims description 10
- GEHJYWRUCIMESM-UHFFFAOYSA-L sodium sulfite Chemical compound [Na+].[Na+].[O-]S([O-])=O GEHJYWRUCIMESM-UHFFFAOYSA-L 0.000 claims description 10
- PCLIMKBDDGJMGD-UHFFFAOYSA-N N-bromosuccinimide Chemical compound BrN1C(=O)CCC1=O PCLIMKBDDGJMGD-UHFFFAOYSA-N 0.000 claims description 9
- 239000003795 chemical substances by application Substances 0.000 claims description 9
- LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 claims description 8
- 229910021591 Copper(I) chloride Inorganic materials 0.000 claims description 7
- 229940045803 cuprous chloride Drugs 0.000 claims description 7
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 6
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 6
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 claims description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 6
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 6
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 claims description 6
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims description 6
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 claims description 5
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 claims description 5
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 claims description 5
- VZTDIZULWFCMLS-UHFFFAOYSA-N ammonium formate Chemical compound [NH4+].[O-]C=O VZTDIZULWFCMLS-UHFFFAOYSA-N 0.000 claims description 5
- 239000003054 catalyst Substances 0.000 claims description 5
- OXBLHERUFWYNTN-UHFFFAOYSA-M copper(I) chloride Chemical compound [Cu]Cl OXBLHERUFWYNTN-UHFFFAOYSA-M 0.000 claims description 5
- 235000019253 formic acid Nutrition 0.000 claims description 5
- 239000001257 hydrogen Substances 0.000 claims description 5
- 229910052739 hydrogen Inorganic materials 0.000 claims description 5
- 235000010265 sodium sulphite Nutrition 0.000 claims description 5
- 239000008096 xylene Substances 0.000 claims description 5
- AMQJEAYHLZJPGS-UHFFFAOYSA-N N-Pentanol Chemical compound CCCCCO AMQJEAYHLZJPGS-UHFFFAOYSA-N 0.000 claims description 4
- JRNVZBWKYDBUCA-UHFFFAOYSA-N N-chlorosuccinimide Chemical compound ClN1C(=O)CCC1=O JRNVZBWKYDBUCA-UHFFFAOYSA-N 0.000 claims description 4
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 4
- ZSIAUFGUXNUGDI-UHFFFAOYSA-N hexan-1-ol Chemical compound CCCCCCO ZSIAUFGUXNUGDI-UHFFFAOYSA-N 0.000 claims description 4
- 150000002431 hydrogen Chemical group 0.000 claims description 4
- 229910052751 metal Inorganic materials 0.000 claims description 4
- 239000002184 metal Substances 0.000 claims description 4
- XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 claims description 4
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims description 4
- 235000010288 sodium nitrite Nutrition 0.000 claims description 4
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 claims description 4
- JQJPBYFTQAANLE-UHFFFAOYSA-N Butyl nitrite Chemical compound CCCCON=O JQJPBYFTQAANLE-UHFFFAOYSA-N 0.000 claims description 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 3
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 3
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 3
- -1 lithium aluminum hydride Chemical compound 0.000 claims description 3
- 239000001103 potassium chloride Substances 0.000 claims description 3
- 235000011164 potassium chloride Nutrition 0.000 claims description 3
- 229910000029 sodium carbonate Inorganic materials 0.000 claims description 3
- JVBXVOWTABLYPX-UHFFFAOYSA-L sodium dithionite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])=O JVBXVOWTABLYPX-UHFFFAOYSA-L 0.000 claims description 3
- YRIZYWQGELRKNT-UHFFFAOYSA-N 1,3,5-trichloro-1,3,5-triazinane-2,4,6-trione Chemical compound ClN1C(=O)N(Cl)C(=O)N(Cl)C1=O YRIZYWQGELRKNT-UHFFFAOYSA-N 0.000 claims description 2
- MENYRYNFSIBDQN-UHFFFAOYSA-N 5,5-dibromoimidazolidine-2,4-dione Chemical compound BrC1(Br)NC(=O)NC1=O MENYRYNFSIBDQN-UHFFFAOYSA-N 0.000 claims description 2
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 claims description 2
- IMROMDMJAWUWLK-UHFFFAOYSA-N Ethenol Chemical compound OC=C IMROMDMJAWUWLK-UHFFFAOYSA-N 0.000 claims description 2
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-diisopropylethylamine Substances CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 claims description 2
- PHSPJQZRQAJPPF-UHFFFAOYSA-N N-alpha-Methylhistamine Chemical compound CNCCC1=CN=CN1 PHSPJQZRQAJPPF-UHFFFAOYSA-N 0.000 claims description 2
- IOVCWXUNBOPUCH-UHFFFAOYSA-N Nitrous acid Chemical compound ON=O IOVCWXUNBOPUCH-UHFFFAOYSA-N 0.000 claims description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 claims description 2
- 239000007868 Raney catalyst Substances 0.000 claims description 2
- NPXOKRUENSOPAO-UHFFFAOYSA-N Raney nickel Chemical compound [Al].[Ni] NPXOKRUENSOPAO-UHFFFAOYSA-N 0.000 claims description 2
- 229910000564 Raney nickel Inorganic materials 0.000 claims description 2
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 claims description 2
- DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical compound [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 claims description 2
- DSVGQVZAZSZEEX-UHFFFAOYSA-N [C].[Pt] Chemical compound [C].[Pt] DSVGQVZAZSZEEX-UHFFFAOYSA-N 0.000 claims description 2
- KXKVLQRXCPHEJC-UHFFFAOYSA-N acetic acid trimethyl ester Natural products COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 claims description 2
- VDQQXEISLMTGAB-UHFFFAOYSA-N chloramine T Chemical compound [Na+].CC1=CC=C(S(=O)(=O)[N-]Cl)C=C1 VDQQXEISLMTGAB-UHFFFAOYSA-N 0.000 claims description 2
- ORTQZVOHEJQUHG-UHFFFAOYSA-L copper(II) chloride Chemical compound Cl[Cu]Cl ORTQZVOHEJQUHG-UHFFFAOYSA-L 0.000 claims description 2
- VLKZOEOYAKHREP-UHFFFAOYSA-N hexane Substances CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims description 2
- OWFXIOWLTKNBAP-UHFFFAOYSA-N isoamyl nitrite Chemical compound CC(C)CCON=O OWFXIOWLTKNBAP-UHFFFAOYSA-N 0.000 claims description 2
- 239000012280 lithium aluminium hydride Substances 0.000 claims description 2
- UKVIEHSSVKSQBA-UHFFFAOYSA-N methane;palladium Chemical group C.[Pd] UKVIEHSSVKSQBA-UHFFFAOYSA-N 0.000 claims description 2
- WXZMFSXDPGVJKK-UHFFFAOYSA-N pentaerythritol Chemical compound OCC(CO)(CO)CO WXZMFSXDPGVJKK-UHFFFAOYSA-N 0.000 claims description 2
- 229910000027 potassium carbonate Inorganic materials 0.000 claims description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims description 2
- JQRYUMGHOUYJFW-UHFFFAOYSA-N pyridine;trihydrobromide Chemical compound [Br-].[Br-].[Br-].C1=CC=[NH+]C=C1.C1=CC=[NH+]C=C1.C1=CC=[NH+]C=C1 JQRYUMGHOUYJFW-UHFFFAOYSA-N 0.000 claims description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-O pyridinium Chemical compound C1=CC=[NH+]C=C1 JUJWROOIHBZHMG-UHFFFAOYSA-O 0.000 claims description 2
- 239000012279 sodium borohydride Substances 0.000 claims description 2
- 229910000033 sodium borohydride Inorganic materials 0.000 claims description 2
- SRRKNRDXURUMPP-UHFFFAOYSA-N sodium disulfide Chemical compound [Na+].[Na+].[S-][S-] SRRKNRDXURUMPP-UHFFFAOYSA-N 0.000 claims description 2
- 235000010267 sodium hydrogen sulphite Nutrition 0.000 claims description 2
- 229910052979 sodium sulfide Inorganic materials 0.000 claims description 2
- GRVFOGOEDUUMBP-UHFFFAOYSA-N sodium sulfide (anhydrous) Chemical compound [Na+].[Na+].[S-2] GRVFOGOEDUUMBP-UHFFFAOYSA-N 0.000 claims description 2
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 claims description 2
- 235000019345 sodium thiosulphate Nutrition 0.000 claims description 2
- 229950009390 symclosene Drugs 0.000 claims description 2
- XXROGKLTLUQVRX-UHFFFAOYSA-N allyl alcohol Chemical compound OCC=C XXROGKLTLUQVRX-UHFFFAOYSA-N 0.000 claims 2
- 230000026030 halogenation Effects 0.000 claims 1
- 239000002994 raw material Substances 0.000 abstract description 16
- 230000009286 beneficial effect Effects 0.000 abstract description 8
- 238000009776 industrial production Methods 0.000 abstract description 7
- 230000007613 environmental effect Effects 0.000 abstract description 5
- 230000008901 benefit Effects 0.000 abstract description 4
- 239000003814 drug Substances 0.000 abstract description 4
- 239000002360 explosive Substances 0.000 abstract description 4
- 230000015572 biosynthetic process Effects 0.000 abstract description 3
- 229940079593 drug Drugs 0.000 abstract description 3
- 238000003786 synthesis reaction Methods 0.000 abstract description 3
- 231100000331 toxic Toxicity 0.000 abstract description 3
- 230000002588 toxic effect Effects 0.000 abstract description 3
- 238000003756 stirring Methods 0.000 description 12
- 239000012074 organic phase Substances 0.000 description 10
- 239000007788 liquid Substances 0.000 description 8
- 239000000047 product Substances 0.000 description 8
- 239000007787 solid Substances 0.000 description 8
- 239000008346 aqueous phase Substances 0.000 description 6
- 238000010992 reflux Methods 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 239000000706 filtrate Substances 0.000 description 5
- 238000001914 filtration Methods 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- IKCLCGXPQILATA-UHFFFAOYSA-N 2-chlorobenzoic acid Chemical compound OC(=O)C1=CC=CC=C1Cl IKCLCGXPQILATA-UHFFFAOYSA-N 0.000 description 4
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 4
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Chemical compound BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 4
- 238000001816 cooling Methods 0.000 description 4
- 238000001035 drying Methods 0.000 description 4
- 238000010438 heat treatment Methods 0.000 description 4
- VAMXMNNIEUEQDV-UHFFFAOYSA-N methyl anthranilate Chemical compound COC(=O)C1=CC=CC=C1N VAMXMNNIEUEQDV-UHFFFAOYSA-N 0.000 description 4
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 4
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 4
- 238000005406 washing Methods 0.000 description 4
- IBSQPLPBRSHTTG-UHFFFAOYSA-N 1-chloro-2-methylbenzene Chemical compound CC1=CC=CC=C1Cl IBSQPLPBRSHTTG-UHFFFAOYSA-N 0.000 description 3
- AOXPHVNMBPFOFS-UHFFFAOYSA-N methyl 2-nitrobenzoate Chemical compound COC(=O)C1=CC=CC=C1[N+]([O-])=O AOXPHVNMBPFOFS-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 2
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 2
- TWLLPUMZVVGILS-UHFFFAOYSA-N Ethyl 2-aminobenzoate Chemical compound CCOC(=O)C1=CC=CC=C1N TWLLPUMZVVGILS-UHFFFAOYSA-N 0.000 description 2
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 239000003472 antidiabetic agent Substances 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 238000007664 blowing Methods 0.000 description 2
- 229910052794 bromium Inorganic materials 0.000 description 2
- 238000005660 chlorination reaction Methods 0.000 description 2
- 239000000460 chlorine Substances 0.000 description 2
- 229910052801 chlorine Inorganic materials 0.000 description 2
- CPNMAYYYYSWTIV-UHFFFAOYSA-N ethyl 2-nitrobenzoate Chemical compound CCOC(=O)C1=CC=CC=C1[N+]([O-])=O CPNMAYYYYSWTIV-UHFFFAOYSA-N 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- UHZYTMXLRWXGPK-UHFFFAOYSA-N phosphorus pentachloride Chemical compound ClP(Cl)(Cl)(Cl)Cl UHZYTMXLRWXGPK-UHFFFAOYSA-N 0.000 description 2
- 239000012286 potassium permanganate Substances 0.000 description 2
- 230000001376 precipitating effect Effects 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 description 1
- VSTXCZGEEVFJES-UHFFFAOYSA-N 1-cycloundecyl-1,5-diazacycloundec-5-ene Chemical compound C1CCCCCC(CCCC1)N1CCCCCC=NCCC1 VSTXCZGEEVFJES-UHFFFAOYSA-N 0.000 description 1
- JVHXJTBJCFBINQ-ADAARDCZSA-N Dapagliflozin Chemical compound C1=CC(OCC)=CC=C1CC1=CC([C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)=CC=C1Cl JVHXJTBJCFBINQ-ADAARDCZSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 1
- 229940123518 Sodium/glucose cotransporter 2 inhibitor Drugs 0.000 description 1
- 229960000583 acetic acid Drugs 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 238000005893 bromination reaction Methods 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 229960003834 dapagliflozin Drugs 0.000 description 1
- VRLDVERQJMEPIF-UHFFFAOYSA-N dbdmh Chemical compound CC1(C)N(Br)C(=O)N(Br)C1=O VRLDVERQJMEPIF-UHFFFAOYSA-N 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000009103 reabsorption Effects 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
- C07C51/347—Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups
- C07C51/363—Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups by introduction of halogen; by substitution of halogen atoms by other halogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C201/00—Preparation of esters of nitric or nitrous acid or of compounds containing nitro or nitroso groups bound to a carbon skeleton
- C07C201/06—Preparation of nitro compounds
- C07C201/12—Preparation of nitro compounds by reactions not involving the formation of nitro groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C227/04—Formation of amino groups in compounds containing carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C227/14—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof
- C07C227/18—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof by reactions involving amino or carboxyl groups, e.g. hydrolysis of esters or amides, by formation of halides, salts or esters
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
The application discloses a preparation method of 5-bromo-2-chlorobenzoic acid, belonging to the field of drug synthesis. The preparation method comprises the following steps: (1) carrying out esterification reaction on 2-nitrobenzoic acid and alcohol to obtain a first intermediate; (2) carrying out reduction reaction on the first intermediate and a first reducing agent to obtain a second intermediate; (3) carrying out halogenation reaction on the second intermediate and the first halogenated reagent, adding a second reducing agent into a reaction system after the halogenation reaction is finished, carrying out reduction reaction, and then carrying out hydrolysis reaction on the second intermediate and alkali to obtain 5-bromo-2-aminobenzoic acid; (4) the 5-bromo-2-aminobenzoic acid and a diazotization reagent undergo a diazotization reaction, and then undergo a halogenation reaction with a second halogenating reagent to obtain the 5-bromo-2-chlorobenzoic acid. The preparation method has the advantages of mild reaction conditions, safe and simple operation, short production period, cheap and easily-obtained raw materials and solvents, no explosive products and no highly toxic products, and is beneficial to environmental protection; the prepared product has higher yield and purity, and is beneficial to industrial production.
Description
Technical Field
The application belongs to the field of drug synthesis, and particularly relates to a preparation method of 5-bromo-2-chlorobenzoic acid.
Background
5-bromo-2-chlorobenzoic acid has important use in the synthesis of medicine, is the synthetic raw material of hypoglycemic drugs such as engelet, dapagliflozin, soagliflozin, egagliflozin, and the like, and the drug is a sodium-glucose cotransporter 2 inhibitor which can reduce the reabsorption of the kidney to glucose and is used for treating type 2 diabetes patients.
According to literature reports, there are two main methods for synthesizing 5-bromo-2-chlorobenzoic acid:
the first method comprises the following steps: toluene is used as an initial raw material and reacts with chlorine to obtain o-chlorotoluene, potassium permanganate is used for oxidizing methyl to obtain o-chlorobenzoic acid, and then bromination reaction is carried out on the o-chlorobenzoic acid and liquid bromine or NBS to obtain the 5-bromine-2-chlorobenzoic acid. However, the method is very easy to generate dichlorinated impurity in the toluene chlorination reaction, and the impurity is not easy to remove; when potassium permanganate is used for carrying out oxidation reaction on methyl, the product yield is low and is only 55 percent, and the industrial production is not facilitated. The synthetic route of the method is as follows:
the second method comprises the following steps: the method comprises the steps of taking o-chlorotoluene as a starting material, reacting with chlorine by taking phosphorus pentachloride as a catalyst under the irradiation of ultraviolet light to obtain o-chlorotrifluoromethylene, hydrolyzing with glacial acetic acid to obtain o-chlorobenzoic acid, and bromizing the o-chlorobenzoic acid with liquid bromine or NBS to obtain 5-bromine-2-chlorobenzoic acid. In the method, during chlorination reaction, phosphorus pentachloride and o-chlorotoluene are solid-liquid two phases at the early stage of the reaction, so that the penetration rate of ultraviolet rays to common glass is poor, the reaction time is longer, and reduced pressure distillation purification is needed after the reaction is finished, so that the yield is lower and is only 40%. Therefore, the method has the advantages of longer production period, lower yield and higher environmental protection pressure, and is not beneficial to industrial production. The synthetic route of the method is as follows:
therefore, how to provide a preparation method of 5-bromo-2-chlorobenzoic acid which is safe, high in yield, short in production period and suitable for industrial production becomes a problem to be solved urgently.
Disclosure of Invention
In order to solve the problems, the application provides a preparation method of 5-bromo-2-chlorobenzoic acid, which has mild reaction conditions, safe and simple operation, short production period, cheap and easily obtained raw materials and solvents, no explosive product and no toxic product, and is beneficial to environmental protection; the prepared product has higher yield and purity, and is beneficial to industrial production.
The application provides a preparation method of 5-bromo-2-chlorobenzoic acid, which comprises the following steps:
(1) carrying out esterification reaction on 2-nitrobenzoic acid and alcohol to obtain a first intermediate;
(2) carrying out reduction reaction on the first intermediate obtained in the step (1) and a first reducing agent to obtain a second intermediate;
(3) performing halogenation reaction on the second intermediate obtained in the step (2) and a first halogenated reagent, adding a second reducing agent into a reaction system after the halogenation reaction is completed, performing reduction reaction, and performing hydrolysis reaction on the second intermediate and alkali to obtain 5-bromo-2-aminobenzoic acid;
(4) and (4) carrying out diazotization reaction on the 5-bromo-2-aminobenzoic acid obtained in the step (3) and a diazotization reagent, and then carrying out halogenation reaction on the diazotization reagent and a second halogenating reagent to obtain the 5-bromo-2-chlorobenzoic acid.
The reaction scheme of the present application is as follows:
r1 and R2 are independently selected from C1-C6 alkyl, preferably methyl, ethyl, n-propyl, isopropyl, n-butyl or tert-butyl, more preferably methyl, ethyl, isopropyl or n-butyl.
Preferably, the molar ratio of 2-nitrobenzoic acid to alcohol in step (1) is 1: (1 to 3), more preferably 1: (1.5-2).
Preferably, the alcohol in step (1) is selected from methanol, ethanol, n-propanol, isopropanol, n-butanol, t-butanol, n-pentanol, n-hexanol, ethylene glycol, glycerol, propylene glycol, pentaerythritol, propylene alcohol or vinyl alcohol, more preferably methanol, ethanol, isopropanol, n-butanol or t-butanol.
Preferably, the solvent for the esterification reaction in step (1) is dichloromethane, toluene, xylene or alcohol in step (1).
Preferably, the first reducing agent used in the reduction reaction in step (2) is selected from hydrogen, formic acid, ammonium formate, iron powder, zinc powder, sodium sulfide, sodium disulfide, lithium aluminum hydride or sodium borohydride, more preferably hydrogen, formic acid, ammonium formate, iron powder or zinc powder; when the first reducing agent is hydrogen, formic acid or ammonium formate, adding a metal catalyst; the metal catalyst is selected from palladium carbon, platinum carbon or Raney nickel.
Preferably, the solvent for the reduction reaction of step (2) is one or more of water, methanol, ethanol, n-propanol, isopropanol, n-butanol, ethyl acetate and toluene, more preferably one or more of water, methanol, ethanol and ethyl acetate.
Preferably, the reaction temperature of the reduction reaction in the step (2) is 0-90 ℃, and more preferably 20-70 ℃.
Preferably, the molar ratio of the second intermediate to the first halogenating agent in step (3) is 1: (0.8 to 2), more preferably 1: (0.8 to 1.5).
Preferably, the first halogen reagent in step (3) is selected from elemental bromine, N-bromosuccinimide (NBS), pyridinium Perbromide Hydrobromide (PHP), dibromohydantoin (DBDMH), pyridinium tribromide (PBP), tetrabromocycloketone, phosphorus tribromide, more preferably elemental bromine, N-bromosuccinimide.
Preferably, the base in step (3) is one or more of sodium carbonate, sodium bicarbonate, potassium carbonate, sodium hydroxide, pyridine, triethylamine, N-diisopropylethylamine and 1, 8-diazabicycloundec-7-ene (DBU), more preferably sodium hydroxide or sodium carbonate;
preferably, the solvent for the halogenation reaction in the step (3) is one or more of ethyl acetate, methyl acetate, carbon tetrachloride, dichloromethane, acetonitrile, N-Dimethylformamide (DFM), dimethyl sulfoxide (DMSO), toluene, xylene, N-hexane and cyclohexane, and more preferably one or more of dichloromethane, ethyl acetate, xylene and toluene.
Preferably, the reaction temperature of the halogenation reaction in the step (3) is-20 to 50 ℃, and more preferably-10 to 30 ℃.
Preferably, the second reducing agent in step (3) is selected from sodium sulfite, sodium bisulfite, sodium thiosulfate or sodium dithionite (sodium hydrosulfite). After the halogenation reaction in the step (3) is finished, a second reducing agent is added to remove the excessive halogenating reagent, so that the generation of byproducts can be effectively controlled.
Preferably, the reaction temperature of the diazotization reaction in the step (4) is-20-50 ℃, and more preferably-10 ℃.
Preferably, the molar ratio of the 5-bromo-2-aminobenzoic acid, the diazotizing agent and the second halogenating agent in step (4) is 1: (0.9-2): (1.1 to 3), more preferably 1: (1.2-2): (1.5-2.5).
Preferably, the diazotizing agent in step (4) is selected from the group consisting of a combination of sodium nitrite and hydrochloric acid, nitrous acid, n-butyl nitrite or isoamyl nitrite, more preferably a combination of sodium nitrite and hydrochloric acid or n-butyl nitrite.
In the step (4), the second halogenated reagent is one or more of potassium chloride, copper chloride, cuprous chloride, N-chlorosuccinimide, phosphorus oxychloride, trichloroisocyanuric acid and chloramine T, and potassium chloride or cuprous chloride is more preferable.
The solvent for the diazotization reaction and the halogenation reaction in the step (4) is one or more of water, methanol, ethanol, n-propanol, isopropanol, n-butanol, acetonitrile and toluene, and more preferably one or more of water, methanol and acetonitrile.
The application also provides the application of the preparation method of the 5-bromo-2-chlorobenzoic acid in preparing hypoglycemic drugs.
Benefits of the present application include, but are not limited to:
the preparation method of 5-bromo-2-chlorobenzoic acid provided by the application has the advantages of mild reaction conditions, safe and simple operation, short production period, cheap and easily-obtained raw materials and solvents, no explosive products and no highly toxic products, and is beneficial to environmental protection; the prepared product has higher yield and purity, and is beneficial to industrial production.
Detailed Description
The present application will be described in detail with reference to examples, but the present application is not limited to these examples.
The raw materials, solvents and reagents in the examples of the present application were all purchased commercially unless otherwise specified.
Example 1
Adding 2-nitrobenzoic acid (50 g, 0.299 mol) into dichloromethane (200 mL), stirring, adding thionyl chloride (42.7 g, 0.359 mol), heating to reflux temperature, refluxing for 5 hours, and stopping the reaction, wherein the raw material is less than 1% remained; cooling to below 5 ℃, dropwise adding methanol (15 g, 0.469 mol), controlling the temperature below 10 ℃ in the dropwise adding process, stirring for 30 minutes after the dropwise adding is finished, and concentrating under reduced pressure at 40 ℃ to obtain 48.8g of 2-nitrobenzoic acid methyl ester (first intermediate) in a light yellow liquid state, wherein the yield is 90% and the purity is 99.2%.
Example 2
Adding 2-nitrobenzoic acid (50 g, 0.299 mol) into methanol (200 mL), stirring, cooling to 0-5 ℃, dropwise adding thionyl chloride (42.7 g, 0.359 mol), reacting for 1 hour at the temperature of 0-5 ℃ after dropwise adding, slowly heating to reflux temperature after reaction, refluxing for 2 hours until the raw material residue is less than 1%, stopping reaction, and concentrating under reduced pressure at 40 ℃ to obtain 49.3g of yellow liquid methyl 2-nitrobenzoate (first intermediate), wherein the yield is 91% and the purity is 99.3%.
Example 3
2-nitrobenzoic acid (50 g, 0.299 mol) was added to toluene (200 mL), stirred, anhydrous magnesium sulfate (20 g) and ethanol (22 g, 0.478 mol) were added, the temperature was raised to reflux temperature, reflux reaction was carried out for 7 hours, the reaction was stopped when <1% of the raw material remained, the filtrate was concentrated under reduced pressure, and 51.3g of 2-nitrobenzoic acid ethyl ester (first intermediate) was obtained as a pale yellow liquid, with a yield of 87.8% and a purity of 99.6%.
Example 4
Methyl 2-nitrobenzoate (40 g, 0.221 mol) prepared in example 1 or example 2 was added to a 500mL autoclave, methanol (200 mL) and 10% palladium on carbon (2 g) were then added, hydrogen was introduced, the mixture was replaced with 3 times, stirred, pressurized to 0.5MPa, heated to 60 ℃, reacted for 6 hours with <1% of the remaining starting material, cooled to room temperature, filtered, and the filtrate was concentrated under reduced pressure at 50 ℃ to obtain 31.4g of methyl 2-aminobenzoate (second intermediate) as a yellow liquid in a yield of 94.1% and a purity of 99.3%.
Example 5
The ethyl 2-nitrobenzoate (40 g, 0.205 mol) prepared in example 3 was added to a 500mL autoclave, methanol (200 mL) and 10% palladium on carbon (2 g) were then added, hydrogen gas was introduced to replace 3 times, stirring was carried out, pressure was increased to 0.5MPa, the temperature was raised to 60 ℃, reaction was carried out for 6 hours, the raw material residue was <1%, temperature was reduced to room temperature, filtration was carried out, and the filtrate was concentrated under reduced pressure at 50 ℃ to obtain 32.3g of yellow liquid ethyl 2-aminobenzoate (second intermediate), yield was 95.4%, and purity was 99.2%.
Example 6
Adding methyl 2-aminobenzoate (30 g, 0.198 mol) prepared in example 4 into dichloromethane (180 mL), stirring, cooling to 10 ℃, starting to dropwise add a dichloromethane solution containing bromine (31.7 g, 0.198mol and 60mL of dichloromethane), controlling the temperature to be less than 20 ℃ in the dropwise adding process, stirring at room temperature for 1 hour after the dropwise adding is finished, dropwise adding a 10% sodium sulfite solution (200 mL) when the raw material is less than 1% left, separating, keeping an organic phase, adding water (120 g) into the organic phase, stirring, adjusting the pH value to 1 with hydrochloric acid, separating, keeping an aqueous phase, adding sodium hydroxide (8.5 g) (pH is greater than 10), stirring for 1 hour, washing the aqueous phase with dichloromethane (60 mL), discarding the organic phase, adjusting the pH value of the aqueous phase with hydrochloric acid to 6-7, precipitating a large amount of solid, filtering, drying by air blowing at 50 ℃ to obtain 37.8g of 5-bromo-2-aminobenzoic acid as a white solid, the yield was 88.2% and the purity was 99.7%.
Example 7
Adding ethyl 2-aminobenzoate (30 g, 0.182 mol) prepared in example 5 into dichloromethane (180 mL), stirring, cooling to 10 ℃, starting to dropwise add a dichloromethane solution containing bromine (29.1 g, 0.182mol and 60mL of dichloromethane), controlling the temperature to be less than 20 ℃ in the dropwise adding process, stirring at room temperature for 1 hour after the dropwise adding is finished, dropwise adding a 10% sodium sulfite solution (200 mL) when the raw material is less than 1% left, separating, keeping an organic phase, adding water (120 g) into the organic phase, stirring, adjusting the pH value to 1 with hydrochloric acid, separating, keeping an aqueous phase, adding sodium hydroxide (7.8 g) (pH is greater than 10), stirring for 2 hours, washing the aqueous phase with dichloromethane (60 mL), discarding the organic phase, adjusting the pH value of the aqueous phase with hydrochloric acid to 6-7, precipitating a large amount of solid, filtering, drying by air blowing at 50 ℃ to obtain 34g of 5-bromo-2-aminobenzoic acid as a white solid, the yield was 86.6% and the purity was 99.7%.
Example 8
5-bromo-2-aminobenzoic acid prepared in example 6 or example 7 (30 g, 0.139 mol) was added to water (90 g), stirred, cooled to-5 ℃ and concentrated hydrochloric acid (36 mL) was added dropwise, with the temperature controlled to be less than 0 ℃ during the dropwise addition, stirred for 30 minutes after the dropwise addition was completed, after the solid was completely dissolved, the dropwise addition of an aqueous solution of sodium nitrite (12.5 g, 0.181mol, 30g of water) was started, and stirred for 1 hour after the dropwise addition was completed. Dropwise adding a hydrochloric acid-cuprous chloride solution (21 g of cuprous chloride, 0.212mol of hydrochloric acid, 37.5mL of hydrochloric acid and 37.5g of water) into the reaction system, controlling the temperature to be less than 5 ℃ in the dropwise adding process, heating to room temperature after the dropwise adding is finished, reacting for 8 hours, extracting the residual raw material of less than 1% twice by using ethyl acetate, combining organic phases, washing once by using saturated saline solution, separating liquid, adding anhydrous sodium sulfate into the organic phase for drying, filtering, and evaporating the filtrate at 50 ℃ under reduced pressure to dryness to obtain 27.8g of 5-bromo-2-chlorobenzoic acid as a white solid, wherein the yield is 85% and the purity is 99.4%.
Example 9
5-bromo-2-aminobenzoic acid prepared in example 6 or example 7 (30 g, 0.139 mol) was added to water (90 g), stirred, cooled to 5 ℃ and concentrated hydrochloric acid (36 mL) was added dropwise, with the temperature controlled to be less than 10 ℃ during the dropwise addition, stirred for 30 minutes after the dropwise addition was completed, after the solid was completely dissolved, the dropwise addition of an aqueous solution of sodium sulfite (12.5 g, 0.181mol, water 30 g) was started, and stirred for 1 hour after the dropwise addition was completed. Dropwise adding a hydrochloric acid-cuprous chloride solution (21 g of cuprous chloride, 0.212mol of hydrochloric acid, 37.5mL of hydrochloric acid and 37.5g of water) into the reaction system, controlling the temperature to be less than 5 ℃ in the dropwise adding process, heating to room temperature after the dropwise adding is finished, reacting for 8 hours, extracting the residual raw material of less than 1% twice by using ethyl acetate, combining organic phases, washing once by using saturated saline solution, separating liquid, adding anhydrous sodium sulfate into the organic phase for drying, filtering, and evaporating the filtrate at 50 ℃ under reduced pressure to dryness to obtain 27.5g of 5-bromo-2-chlorobenzoic acid as a white solid, wherein the yield is 84.1% and the purity is 99.5%.
Examples 1 to 3 are the preparation steps of the first intermediate, the yield of which reaches 87.8% or more and the purity of which reaches 99.2% or more; examples 4 to 5 are the preparation steps of the second intermediate, the yield of the second intermediate reaches more than 94.1%, and the purity reaches 99.2%; example 6-7 is a preparation procedure of 5-bromo-2-aminobenzoic acid, the yield of 5-bromo-2-aminobenzoic acid reached over 86.6%, and the purity reached 99.7%; example 8-9 is a preparation procedure of 5-bromo-2-chlorobenzoic acid, and the yield of 5-bromo-2-chlorobenzoic acid was 84.1% or more and the purity was 99.4% or more.
According to the embodiment, the preparation method has mild reaction conditions, is safe and simple to operate, reduces the emission of acid gas, and is beneficial to environmental protection; the used raw materials and solvents are cheap and easy to obtain, and no dangerous chemical raw materials such as strong toxicity and explosive are generated; the product prepared in each step has high yield and purity, and is suitable for industrial production.
The above description is only an example of the present application, and the protection scope of the present application is not limited by these specific examples, but is defined by the claims of the present application. Various modifications and changes may occur to those skilled in the art. Any modification, equivalent replacement, improvement, etc. made within the technical idea and principle of the present application should be included in the protection scope of the present application.
Claims (10)
1. A preparation method of 5-bromo-2-chlorobenzoic acid is characterized by comprising the following steps:
(1) carrying out esterification reaction on 2-nitrobenzoic acid and alcohol to obtain a first intermediate;
(2) carrying out reduction reaction on the first intermediate obtained in the step (1) and a first reducing agent to obtain a second intermediate;
(3) performing halogenation reaction on the second intermediate obtained in the step (2) and a first halogenated reagent, adding a second reducing agent into a reaction system after the halogenation reaction is completed, performing reduction reaction, and performing hydrolysis reaction on the second intermediate and alkali to obtain 5-bromo-2-aminobenzoic acid;
(4) and (4) carrying out diazotization reaction on the 5-bromo-2-aminobenzoic acid obtained in the step (3) and a diazotization reagent, and then carrying out halogenation reaction on the diazotization reagent and a second halogenating reagent to obtain the 5-bromo-2-chlorobenzoic acid.
2. The production method according to claim 1, wherein the molar ratio of 2-nitrobenzoic acid to alcohol in the step (1) is 1: (1-3).
3. The method according to claim 1, wherein the alcohol in the step (1) is selected from methanol, ethanol, n-propanol, isopropanol, n-butanol, t-butanol, n-pentanol, n-hexanol, ethylene glycol, glycerol, propylene glycol, pentaerythritol, allyl alcohol, and vinyl alcohol;
the solvent for the esterification reaction in the step (1) is dichloromethane, toluene, xylene or alcohol in the step (1).
4. The preparation method according to claim 1, wherein the first reducing agent used in the reduction reaction in step (2) is selected from hydrogen gas, formic acid, ammonium formate, iron powder, zinc powder, sodium sulfide, sodium disulfide, lithium aluminum hydride, or sodium borohydride; when the first reducing agent is hydrogen, formic acid or ammonium formate, adding a metal catalyst; the metal catalyst is selected from palladium carbon, platinum carbon or Raney nickel;
the solvent of the reduction reaction in the step (2) is one or more of water, methanol, ethanol, n-propanol, isopropanol, n-butanol, ethyl acetate and toluene;
the reaction temperature of the reduction reaction in the step (2) is 0-90 ℃.
5. The method according to claim 1, wherein the molar ratio of the second intermediate to the first halogenating agent in the step (3) is 1: (0.8-2).
6. The method of claim 1, wherein the first halogenating agent in step (3) is selected from elemental bromine, N-bromosuccinimide, pyridinium perbromide hydrobromide, dibromohydantoin, pyridinium tribromide, tetrabromocycloketone, phosphorus tribromide;
the alkali in the step (3) is one or more of sodium carbonate, sodium bicarbonate, potassium carbonate, sodium hydroxide, pyridine, triethylamine, N-diisopropylethylamine and 1, 8-diazabicycloundecen-7-ene;
the solvent of the halogenation reaction in the step (3) is one or more of ethyl acetate, methyl acetate, carbon tetrachloride, dichloromethane, acetonitrile, N-dimethylformamide, dimethyl sulfoxide, toluene, xylene, N-hexane and cyclohexane;
the reaction temperature of the halogenation reaction in the step (3) is-20-50 ℃.
7. The method according to claim 1, wherein the second reducing agent in the step (3) is selected from sodium sulfite, sodium bisulfite, sodium thiosulfate and sodium dithionite.
8. The preparation method according to claim 1, wherein the reaction temperature of the diazotization reaction in the step (4) is-20 to 50 ℃.
9. The production method according to claim 1, wherein the molar ratio of the 5-bromo-2-aminobenzoic acid, the diazotizing agent, and the second halogenating agent in the step (4) is 1: (0.9-2): (1.1-3).
10. The method according to claim 1, wherein the diazotizing agent in the step (4) is selected from the group consisting of a combination of sodium nitrite and hydrochloric acid, nitrous acid, n-butyl nitrite, isoamyl nitrite;
in the step (4), the second halogenated reagent is one or more of potassium chloride, copper chloride, cuprous chloride, N-chlorosuccinimide, phosphorus oxychloride, trichloroisocyanuric acid and chloramine T;
the solvent for diazotization and halogenation in the step (4) is one or more of water, methanol, ethanol, n-propanol, isopropanol, n-butanol, acetonitrile and toluene.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111365309.7A CN113801010A (en) | 2021-11-18 | 2021-11-18 | Preparation method of 5-bromo-2-chlorobenzoic acid |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111365309.7A CN113801010A (en) | 2021-11-18 | 2021-11-18 | Preparation method of 5-bromo-2-chlorobenzoic acid |
Publications (1)
Publication Number | Publication Date |
---|---|
CN113801010A true CN113801010A (en) | 2021-12-17 |
Family
ID=78938312
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202111365309.7A Pending CN113801010A (en) | 2021-11-18 | 2021-11-18 | Preparation method of 5-bromo-2-chlorobenzoic acid |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113801010A (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114163309A (en) * | 2021-12-27 | 2022-03-11 | 甘肃皓天医药科技有限责任公司 | Preparation method of dorawirin intermediate |
CN114516806A (en) * | 2022-02-21 | 2022-05-20 | 阜新都创新材料科技有限公司 | Preparation method of 2, 6-dibromo-4-trifluoromethoxy aniline |
WO2023019849A1 (en) * | 2021-08-16 | 2023-02-23 | 浙江奥翔药业股份有限公司 | Method for preparing 5-bromo-2-chloro-benzoic acid as raw material in hypoglycemic drug synthesis |
CN117285411A (en) * | 2023-09-11 | 2023-12-26 | 扬州市普林斯医药科技有限公司 | Preparation method of 2' -bromo-o-fluoro acetophenone |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103596564A (en) * | 2011-06-01 | 2014-02-19 | 株式会社绿十字 | Novel diphenylmethane derivatives as SGLT2 inhibitors |
US20140274918A1 (en) * | 2013-03-18 | 2014-09-18 | Green Cross Corporation | Method for dual inhibition of sglt1 and sglt2 using diphenylmethane derivatives |
CN104744227A (en) * | 2013-12-25 | 2015-07-01 | 重庆博腾制药科技股份有限公司 | 5-bromine-2-chlorobenzaldehyde preparation method |
CN108250060A (en) * | 2018-01-26 | 2018-07-06 | 江苏尚莱特医药化工材料有限公司 | The synthetic method of the bromo- 2- chlorobenzoic acids of 5- |
CN109311861A (en) * | 2016-06-17 | 2019-02-05 | 株式会社大熊制药 | The method for being used to prepare diphenylmethane derivatives |
CN110002989A (en) * | 2019-03-15 | 2019-07-12 | 河北合佳医药科技集团股份有限公司 | A kind of preparation method of the bromo- 2- chlorobenzoic acid of highly selective 5- |
CN110590541A (en) * | 2019-10-16 | 2019-12-20 | 吕东 | Preparation method of 5-bromo-2-chlorobenzoic acid |
-
2021
- 2021-11-18 CN CN202111365309.7A patent/CN113801010A/en active Pending
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103596564A (en) * | 2011-06-01 | 2014-02-19 | 株式会社绿十字 | Novel diphenylmethane derivatives as SGLT2 inhibitors |
US20140274918A1 (en) * | 2013-03-18 | 2014-09-18 | Green Cross Corporation | Method for dual inhibition of sglt1 and sglt2 using diphenylmethane derivatives |
CN104744227A (en) * | 2013-12-25 | 2015-07-01 | 重庆博腾制药科技股份有限公司 | 5-bromine-2-chlorobenzaldehyde preparation method |
CN109311861A (en) * | 2016-06-17 | 2019-02-05 | 株式会社大熊制药 | The method for being used to prepare diphenylmethane derivatives |
CN108250060A (en) * | 2018-01-26 | 2018-07-06 | 江苏尚莱特医药化工材料有限公司 | The synthetic method of the bromo- 2- chlorobenzoic acids of 5- |
CN110002989A (en) * | 2019-03-15 | 2019-07-12 | 河北合佳医药科技集团股份有限公司 | A kind of preparation method of the bromo- 2- chlorobenzoic acid of highly selective 5- |
CN110590541A (en) * | 2019-10-16 | 2019-12-20 | 吕东 | Preparation method of 5-bromo-2-chlorobenzoic acid |
Non-Patent Citations (1)
Title |
---|
JUN LIAO等: "Synthesis and biological evaluation of novel fluconazole analogues bearing 1,3,4-oxadiazole moiety as potent antifungal agents", 《ARCHIVES OF PHARMACAL RESEARCH》 * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2023019849A1 (en) * | 2021-08-16 | 2023-02-23 | 浙江奥翔药业股份有限公司 | Method for preparing 5-bromo-2-chloro-benzoic acid as raw material in hypoglycemic drug synthesis |
CN114163309A (en) * | 2021-12-27 | 2022-03-11 | 甘肃皓天医药科技有限责任公司 | Preparation method of dorawirin intermediate |
CN114516806A (en) * | 2022-02-21 | 2022-05-20 | 阜新都创新材料科技有限公司 | Preparation method of 2, 6-dibromo-4-trifluoromethoxy aniline |
CN117285411A (en) * | 2023-09-11 | 2023-12-26 | 扬州市普林斯医药科技有限公司 | Preparation method of 2' -bromo-o-fluoro acetophenone |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN113801010A (en) | Preparation method of 5-bromo-2-chlorobenzoic acid | |
CN111393427B (en) | Synthetic method of sulfuryl pyraflufen | |
CN105622382B (en) | A kind of synthetic method of the bromo- 2- chlorobenzoic acids of 5- | |
CN111848406B (en) | Preparation method of 2-chloro-4-fluoro-5-nitrobenzaldehyde | |
CN110878084A (en) | Preparation method of nicosulfuron original drug | |
CN109438405A (en) | A kind of synthetic method of 3- (benzyloxy) -4- oxo -4H- pyrans -2- carboxylic acid | |
CN110372551B (en) | The preparation method of 3-mercaptopropionic acid | |
CN104402909B (en) | A kind of synthetic method of cefoxitin acid | |
CN113278021B (en) | Preparation method of 1, 7-diazaspiro [3.5] nonane-7-tert-butyl formate and oxalate thereof | |
CA2694939C (en) | Process for producing toluidine compound | |
CN116730945B (en) | Saccharin preparation method | |
CN112661705A (en) | Synthetic method of avanafil impurity | |
CN108911989B (en) | Synthesis method of 2-methyl-3-trifluoromethylaniline | |
CN113735785A (en) | Preparation method of 3, 6-dichloropyrazine-2-carbonitrile | |
CN101696185B (en) | Synthesizing method of 6-nitro-S-(-)-indoline-2-carboxylic acid | |
EP3652158A1 (en) | Method for preparing pyrimidone compound | |
CN109053716B (en) | Novel process for preparing metopimazine | |
CN111377991B (en) | Preparation method of loteprednol etabonate | |
KR101414866B1 (en) | An alkali metal iodide solution and a method for producing the same | |
CN114163309B (en) | Preparation method of doravirine intermediate | |
JPH01149762A (en) | Production of 4-(alkylsulfonyl)-2-aminophenol | |
CN117777051B (en) | Synthesis method of 2-bromo-5-chlorothiazole-4-carboxylate | |
CN114181139B (en) | Synthesis method of 5-halogenated nicotinic acid | |
WO2005026176A1 (en) | Process for producing 3-chloromethyl-3-cephem derivative | |
CN115197086B (en) | Preparation method of difluoromethoxy-containing m-diamide compound |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20211217 |
|
RJ01 | Rejection of invention patent application after publication |